Klenova A, Georgiev R, Kurtev P, Kurteva G
Department of Radiotherapy, National Hospital of Oncology, Sofia, Bulgaria.
J BUON. 2007 Apr-Jun;12(2):227-32.
Preoperative radiotherapy (RT) at high-dose short-course or at conventional fractions for rectal cancer has proven effect in increasing the tumor control. The aim of this study was to test the impact of 2 different preoperative RT schemes on local recurrence, distant metastasis and survival rates and to defi ne the indications for each of them.
The study included 84 patients with biopsy-proven rectal adenocarcinoma of the middle and lower third, clinically staged T2-T4, N0-2, M0. Group I patients (n=51) received a total dose of 25 Gy in 5 fractions of 5 Gy each for 5 consecutive days; operation was performed 3-5 days later. Group II patients (n=33) received a total dose of 50 Gy in 25 fractions of 2 Gy each in 5 weeks, followed by surgery after 4-5 weeks. Surgery included abdomino-perineal resection (APR) for tumors of the lower half of distal rectum, abdomino-transanal resection (ATR) for tumors of the upper half of distal rectum and anterior resection (AR) for tumors of the middle rectum.
After a median follow-up of 53 months (range 22-84) overall survival (OS) of all patients at 4 years was 84% and the distant metastasis-free survival (DMFS) 82%. For stage II patients only, OS and DMFS was 100% in both preoperative RT groups. For stage III patients, OS in group I and II was 72% and 70%, respectively (p >0.05) and DMFS 66% and 68%, respectively (p >0.05). Local recurrence - free survival (LRFS) for all stages was 94% with 5 x 5 Gy and 25 x 2 Gy; for stage ?? only it was 100% and for stage III only 90%. However, the use of short preoperative 5 x 5 Gy scheme for tumors of the lower third of the rectum and sphincter-saving surgery was accompanied with higher rates of local recurrence: 11% after 5 x 5 Gy vs. 0% after 25 x 2 Gy. Partial tumor regression with 50 Gy of conventional RT was achieved in 79% of the cases. Such regression was not possible to assess for the 5 x 5 Gy group since surgery was performed 3-5 days after RT. No late adverse effects on normal tissues were observed with any scheme of preoperative RT.
The conventional preoperative RT with 50 Gy proved more effective for advanced rectal cancer (T4 or N2) and for sphincter-saving resections for lower-lying tumors. The short scheme 5 x 5 Gy is appropriate for less advanced tumors (T2-3, N0-1), therefore requiring accurate clinical staging.
术前大剂量短程放疗或常规分割放疗已被证实对提高直肠癌的肿瘤控制效果显著。本研究旨在测试两种不同术前放疗方案对局部复发、远处转移及生存率的影响,并明确各自的适用指征。
本研究纳入84例经活检证实为中下段直肠腺癌的患者,临床分期为T2-T4、N0-2、M0。第一组患者(n = 51)连续5天,每天接受5次,每次5 Gy的放疗,总剂量为25 Gy;3-5天后进行手术。第二组患者(n = 33)在5周内接受25次,每次2 Gy的放疗,总剂量为50 Gy,4-5周后进行手术。手术方式包括:对直肠下段肿瘤行腹会阴联合切除术(APR),对直肠上段肿瘤行腹经肛门切除术(ATR),对直肠中段肿瘤行前切除术(AR)。
中位随访53个月(范围22-84个月),所有患者4年总生存率(OS)为84%,无远处转移生存率(DMFS)为82%。仅II期患者,两个术前放疗组的OS和DMFS均为100%。对于III期患者,第一组和第二组的OS分别为72%和70%(p>0.05),DMFS分别为66%和68%(p>0.05)。所有分期的无局部复发生存率(LRFS),5×5 Gy组和25×2 Gy组均为94%;仅II期为100%,仅III期为90%。然而,对于直肠下段肿瘤采用术前短程5×5 Gy方案并保留括约肌手术时,局部复发率较高:5×5 Gy组为11%,而25×2 Gy组为0%。79%的病例通过50 Gy的常规放疗实现了部分肿瘤退缩。由于放疗后3-5天即进行手术,因此无法对5×5 Gy组的肿瘤退缩情况进行评估。任何术前放疗方案均未观察到对正常组织的晚期不良反应。
50 Gy的常规术前放疗对晚期直肠癌(T4或N2)及低位肿瘤的保留括约肌切除术更为有效。短程5×5 Gy方案适用于进展期较低的肿瘤(T2-3,N0-1),因此需要准确的临床分期。